Fresenius Medical Reports Q4 EPS of $0.90

Fresenius Medical FMS reports its Q4 EPS at $0.90, versus the consensus of $0.88. FMS reports its Q4 revenue at $3.17 billion, versus the consensus of $3.17 billion. FMS shares gained 2.32% to $66.10 in pre-market trading. Read more from Benzinga's Company news.